{"name":"Tacere Therapeutics, Inc.","slug":"tacere-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"Tacere Therapeutics, Inc. is a biotechnology company focused on developing innovative therapies for serious diseases with significant unmet medical needs. The company's lead candidate, TT-034, is currently in Phase 1 clinical trials.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-04-17","type":"regulatory","source":"Business Wire","summary":"RNA Interference Research Report 2024: Global Market to Surpass $6.5 Billion by 2034, Fueled by Advancements in Delivery, Rising Investments, Strategic Collaborations, Government & Regulatory Backing ","headline":"RNA Interference Research Report 2024: Global Market to Surpass $6.5 Billion by 2034, Fueled by Advancements in Delivery","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}